Published 5 times
per week by the American Academy of Stock Proctology and
the American Society of Shortsellers
Dr. Stepan N. Stool, A.S.S. Chair
Available by
annual subscription for $1929 or free
Welcome to the The Anals of Stock Proctology, the
new scholarly journal of the American Academy of Stock Proctology, edited
by the world famous founder of the
study of Stock Proctology, Dr. Stepan N. Stool PHandD.
The Anals replaces
Capitalstool's nightly and weekend updates of the
major stock indexes. Now you can get your
nightly stock proctology report in one convenient, uncluttered page, right
here. The Anals will be available for free, for
the immediate future. Soon, however, all advertising and solicitation will
be removed from the Anals, and access to the Anals will be restricted to
subscribers. As a result of the clean format, the Anals will be readily
printable for reading in locations more appropriate to such endeavors,
such as, uh, the kitchen table. Yes.
The remainder of the site, including The Stool
Pigeons Wire, IntradayStool, Stoolhoo, and Stoolchat, will continue to be
free. You will never have to pay for access to these pages.
Previous contributors to Capitalstool will receive a free subscription
period. Prior to going to a subscription format, the voluntary pay
buttons will remain. So feel free to contribute now. Your contribution
will result in a full credit toward your future subscription. Several
of you have already contributed in excess of $500, and you will receive a free
lifetime subscription. Contributors of written content or
illustrations will also receive free subscriptions. That includes all
who achieve the level of Professor of Stock Proctology on the Stool
Pigeons Wire.
Initial subscription rates will be $19.29 quarterly or $74 per year, in
honor of the great bear markets of the 20th century. Actually, 1937 was
pretty bad too, so the Academy may offer a half year subscription for $37.
Latecomers will be able to get a one time, one month trial for, what else?
$6.66.
As always I thank you for your support, and I look forward to many
prosperous years working together with you.
Happy New Year to you and to Bears the world over!
Dr. Stepan N. Stool
Chairman of the Department of Stock Proctology
A.S.S. Endowed Chair
American Society of Shortsellers Endowment
American Academy of Stock Proctology
December 30, 2001
Enrongate (1/10/02) Do
I hear echoes of 1973? The tentacles of the Enron scandal are reaching
deeper and deeper into the bowels of the Harding Hoover administration, a
government bought and paid for, lock, "stock", and barrel by
Enron's money and influence. Evasive answers to reporters' questions,
stonewalling, and a gradual descent into outright coverup, and obstruction
of justice, lie ahead. With Democrats, we get sex scandals. With
Republicans we get abuse of power. The stock market will be dealing with
these issues day in and day out for the remainder of the Harding Hoover
presidency.
We have been through this before. The same kind
of backdrop was part and parcel of the last great bear market. The only
difference is that this time the economic and financial underpinnings are
in even worse shape than they were at the beginning of 1973. And make no
mistake, they were a mess then.
So here we are on Day 1 of Enrongate. Why do I
call it Day 1? Because it's the first day that President Harding Hoover
bothered to answer any press questions. And of course, the President never
talked to anyone at Enron about their problems.
Well.
What the hell'd you expect? A smoking gun? No,
this will grind on and on. The press will keep asking questions, and every
week there will be another damning revelation. Vice President Walking
Heart Attack had 6 meeting with Enron bigwigs. No big deal. But of course
no one ever talked to President Harding Hoover about it. What's that
you say? The auditors destroyed documents? Well, doesn't everybody?
President's top advisor sold all his Enron stock in June? Gosh, what a
lucky guy
So it was Day 1 and what did the markets do?
Nothing, absolutely nothing. A complete yawner. The Nas was up 2, the
Sphincters Index up a buck and a half, and the old Dowager lost 26. The
trading ranges were so narrow, it's not worth talking about.
But under the surface, the deterioration, the
diseased rot, spreads. And the poisonous stench is beginning to seep out
into the open air.
SPX Charts
The VIX index closed at 23.13. No fear there. The index remains in a
two month old top zone. The SPX remains on the edge of dropping back
inside long term downtrend channels. Momentum continues in a huge negative
divergence. This market high wire act is gonna go splat one of these days.
We just don't know which day.
The 6 month cycle oscillator is still in a top configuration. The short
cycle is headed down, and the 10-13 week cycle is in a 4 week old, weak up
phase. Again, it's just a matter of days, until things begin to unravel.
There are
many different ways to try and filter the cycles so that they are visible
on a chart. The one below shows the Nas to be outside its long term cycle
downtrend. No big deal. It always does that at extremes. This is the
essence of an overbought condition. Sometime in the next week or so, the
Nas will be back inside that channel, and still be grossly overbought. The
portfolio sphincters are tapped out. They've been listening to the market
strat-ego-ists, who are recommending the highest level of stock allocation
in the history of the world. The sphincters know it, but they think the
market will correct by just continuing sideways for a few months until the
economy catches up.
Here's
another way of depicting it. The long term cycle in the blue channel is of
12 to 18 months duration. It has flattened, but is still descending. Long
term cycle indicators, not shown here, indicate that this softening in the
downtrend slope was actually an up phase in the 12-18 month cycle dating
back to April. The down leg is just ahead of us, and it will accelerate
down.
Here's Dr.
Stool's favorite Stoolwether, IBM, not because he likes the stock. Because
of the name, silly! If you look at the price portion of the graph you
think, nice uptrend, right? Wrong! Since the last week in October this
stock has been under distribution. Rising price trend, declining momentum.
Yes, everyone knows that BM can float, and stocks can levitate, but they
can only do it for so long. IBM is about to start sinking, just like all those other overpriced
big BM's out there.
Those rumors you heard about today? That was the specialist inventing an
excuse. They are short up the kazoo, and it's time to start dropping this
turd.
Every
night in this space Dr. Stool features a market sector of particular
interest. Last night it was the gold stocks. Tonight, this chart is so
pretty he couldn't resist repeating this sector. Here it is, the Golden Stool, in its pure
form.
Copyright
2002 by Capitalstool.com. All rights reserved. Charts courtesy of
Stockcharts.com.
Capitalstool.com is not guaranteed
to produce a bowel movement within 6-8 hours. Capitalstool.com's purpose is to
present a point of view different from the norm, to inform, educate, and
entertain. The disclaimer, "We don't know, and neither do they," means
just that. Investing and trading are risky business, and no one has all the
answers. Most pundits seem to be wrong most of the time, and this publication is
no different. This publication does not recommend the purchase or sale of any
securities. (Dr. Stool keeps his money in the mattress.) The opinions expressed
herein are just that, opinions, not investment advice. Take what you see here,
and in other media, with a grain of salt. Read and study, everything you can.
Think. Use common sense. Then decide. You are on your own. If, like us, you
don't know, find a competent pro to assist you. Good luck, have fun, and send feedback!
Capitalstool.com
1929 Crash Lane
Browns Mills, NJ 01929
Capitalstool.com provides links to
third party advertisers. These advertisements should not be construed as an
endorsement by Capitalstool.com. Capitalstool.com is not responsible for the
performance or actions of websites to which this site is linked. Data analyzed
on this site is from sources deemed reliable, but not guaranteed, yadda yadda.
Caveat emptor. In other words, you're on your own buddy. Investigate before you
invest. Privacy Policy